Literature DB >> 16416072

[Interventional therapy of acute ST-elevation myocardial infarction in a regional network].

H Schneider1, F Weber, L Paranskaja, C Holzhausen, M Petzsch, C A Nienaber.   

Abstract

BACKGROUND AND OBJECTIVES: Management of acute ST-elevation myocardial infarction (STEMI) demands rapid and complete reflow to the infarct related artery (IRA). Primary PCI (percutaneous coronary intervention) performed by experienced operators is superior to thrombolytic thrombolytic therapy and reduces mortality, occurrence of non-fatal reinfarction and stroke, but is not available in rural Germany. We established a regional infarction-network using established therapeutic guidelines comprising of 1 interventional center and 7 referring community hospitals without PCI facilities. PATIENTS AND METHODS: We analyzed 322 patients with STEMI treated by PCI within the network; 160 patients were transferred from a community hospital without PCI facilities (transfer group (TG): 63.4 yrs., 71.8% men) and 162 patients were admitted directly to the interventional center (center group (CG): 61.7 yrs., 73.8% men). The interval from onset of symptoms to first medical contact was 205 minutes in TG, and 195 minutes in CG (n.s.); 7.8% of the CG and 7.2% of the TG patients were in cardiogenic shock; 95% of patients completed 12- months of follow-up.
RESULTS: In the TG, median transportation time to PCI was 54 minutes. PCI of the infarct-related artery (IRA) was performed in 95.1% of TG patients and in 94.1% of CG patients. In addition, 96% of all patients received a GP IIb/IIIa receptor inhibitor. In case of pre-interventional application of GP IIb/IIIa receptor inhibitor 22.3% of patients revealed TIMI-3 flow of the IRA before PCI. After PCI, normalized flow to the IRAwas documented in 87.5% of CG versus 86.3% of TG. There were no differences between groups with respect to infarct size (TG vs. CG: CK 2482 vs. 2481 U/I; CKMB 302 vs. 264 U/I), mortality (30 days: 5.3 vs. 5.2%, 6 months: 7.3 vs. 7.1%, 12 months: 7.9 vs. 7.8%); NYHA (1.41 vs. 1.43) and left ventricular ejection fraction (0.41 vs. 0.43).
CONCLUSIONS: The organization of a regional STEMI-network with logistic alliance of community hospitals and one experienced interventional center ensures timely PCI treatment of patients with STEMI according to present guidelines even in rural areas, and relegates thrombolytic treatment to bail-out scenarios only.

Entities:  

Mesh:

Year:  2005        PMID: 16416072     DOI: 10.1007/s00392-005-1418-4

Source DB:  PubMed          Journal:  Z Kardiol        ISSN: 0300-5860


  14 in total

1.  Coronary stenting plus platelet glycoprotein IIb/IIIa blockade compared with tissue plasminogen activator in acute myocardial infarction. Stent versus Thrombolysis for Occluded Coronary Arteries in Patients with Acute Myocardial Infarction Study Investigators.

Authors:  A Schömig; A Kastrati; J Dirschinger; J Mehilli; U Schricke; J Pache; S Martinoff; F J Neumann; M Schwaiger
Journal:  N Engl J Med       Date:  2000-08-10       Impact factor: 91.245

2.  Impact of time to treatment on mortality after prehospital fibrinolysis or primary angioplasty: data from the CAPTIM randomized clinical trial.

Authors:  Philippe Gabriel Steg; Eric Bonnefoy; Sylvie Chabaud; Frédéric Lapostolle; Pierre-Yves Dubien; Pascal Cristofini; Alain Leizorovicz; Paul Touboul
Journal:  Circulation       Date:  2003-11-17       Impact factor: 29.690

3.  [Guidelines: Acute coronary syndrome (ACS). II: Acute coronary syndrome with ST-elevation].

Authors:  C W Hamm
Journal:  Z Kardiol       Date:  2004-04

4.  Is primary angioplasty more effective than prehospital fibrinolysis in diabetics with acute myocardial infarction? Data from the CAPTIM randomized clinical trial.

Authors:  Eric Bonnefoy; Philippe Gabriel Steg; Sylvie Chabaud; Pierre-Yves Dubien; Frédéric Lapostolle; Frédéric Boudet; Jean-Michel Lacroute; Frederic Dissait; Gérald Vanzetto; Alain Leizorowicz; Paul Touboul
Journal:  Eur Heart J       Date:  2005-04-19       Impact factor: 29.983

5.  Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study.

Authors:  P Widimský; L Groch; M Zelízko; M Aschermann; F Bednár; H Suryapranata
Journal:  Eur Heart J       Date:  2000-05       Impact factor: 29.983

6.  Clinical practice of primary angioplasty for the treatment of acute myocardial infarction in Germany: results from the MITRA and MIR registries.

Authors:  Ralf Zahn; Rudolf Schiele; Steffen Schneider; Anselm K Gitt; Jochen Senges
Journal:  Z Kardiol       Date:  2002

7.  Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study.

Authors:  Eric Bonnefoy; Frédéric Lapostolle; Alain Leizorovicz; Gabriel Steg; Eugène P McFadden; Pierre Yves Dubien; Simon Cattan; Eric Boullenger; Jacques Machecourt; Jean-Micel Lacroute; Jean Cassagnes; François Dissait; Paul Touboul
Journal:  Lancet       Date:  2002-09-14       Impact factor: 79.321

8.  Long distance transport for primary angioplasty vs immediate thrombolysis in acute myocardial infarction. Final results of the randomized national multicentre trial--PRAGUE-2.

Authors:  P Widimský; T Budesínský; D Vorác; L Groch; M Zelízko; M Aschermann; M Branny; J St'ásek; P Formánek
Journal:  Eur Heart J       Date:  2003-01       Impact factor: 29.983

Review 9.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials.

Authors:  Ellen C Keeley; Judith A Boura; Cindy L Grines
Journal:  Lancet       Date:  2003-01-04       Impact factor: 79.321

10.  Abciximab-supported infarct artery stent implantation for acute myocardial infarction and long-term survival: a prospective, multicenter, randomized trial comparing infarct artery stenting plus abciximab with stenting alone.

Authors:  David Antoniucci; Angela Migliorini; Guido Parodi; Renato Valenti; Alfredo Rodriguez; Albrecht Hempel; Gentian Memisha; Giovanni Maria Santoro
Journal:  Circulation       Date:  2004-04-05       Impact factor: 29.690

View more
  1 in total

Review 1.  [Myocardial infarct and unstable angina pectoris: diagnostics and therapy].

Authors:  M Weber; C Hamm
Journal:  Internist (Berl)       Date:  2007-04       Impact factor: 0.743

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.